Inovio Pharmaceuticals
INO
#10056
Rank
HK$0.53 B
Marketcap
HK$5.20
Share price
-4.84%
Change (1 day)
-54.93%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2026 (TTM): -HK$17.72

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$17.80. In 2025 the company made an earnings per share (EPS) of -HK$14.20 an increase over its 2024 EPS that were of -HK$30.98.

EPS history for Inovio Pharmaceuticals from 1999 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$17.7224.84%
2025-HK$14.20-54.18%
2024-HK$30.98-35.14%
2023-HK$47.76-56.62%
2022-HK$110.11-19.54%
2021-HK$136.8635.9%
2020-HK$100.70-11.57%
2019-HK$113.8815.24%
2018-HK$98.82-2.78%
2017-HK$101.646.93%
2016-HK$95.05134.88%
2015-HK$40.47-29.51%
2014-HK$57.41-57.34%
2013-HK$134.58146.55%
2012-HK$54.5920.83%
2011-HK$45.17-29.41%
2010-HK$64.00-48.48%
2009-HK$124.2310%
2008-HK$112.9411.11%
2007-HK$101.64-41.3%
2006-HK$173.17-66.91%
2005-HK$523.27110.61%
2004-HK$248.46-61.63%
2003-HK$647.50186.67%
2002-HK$225.87
2001N/A-100%
2000-HK$180.70-63.64%
1999-HK$496.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.50-484.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$55.06-409.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.27-157.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$58.19-426.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$28.04-257.48%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$30.48-271.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
HK$6.35-135.68%๐Ÿ‡บ๐Ÿ‡ธ USA